Clinical, pathological, and molecular correlates in ferroportin disease: A study of two novel mutations

Journal of Hepatology

Volumn 49, Issue 4, 2008, Pages 664-671

  Girelli, Domenico ^a   De Domenico, Ivana ^b   Bozzini, Claudia ^a   Campostrini, Natascia ^a   Busti, Fabiana ^a   Castagna, Annalisa ^a   Soriani, Nadia ^c,d   Cremonesi, Laura ^c   Ferrari, Maurizio ^c,d,e   Colombari, Romano ^f   McVey Ward, Diane ^b   Kaplan, Jerry ^b   Corrocher, Roberto ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d Diagnostica e Ricerca San Raffaele   (Italy)

^e VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^f S Bonifacio Hospital   (Italy)

Author keywords

Ferroportin; Hemochromatosis; Hepcidin; Iron overload; Zebrafish

Indexed keywords

FERROPORTIN; HEPCIDIN; IRON;

ADULT; ARTICLE; CLINICAL FEATURE; FEMALE; FERROPORTIN DISEASE; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; HEMOCHROMATOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IN VIVO STUDY; IRON OVERLOAD; LIVER HISTOLOGY; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BIOPSY; CATION TRANSPORT PROTEINS; FEMALE; HEMOCHROMATOSIS; HUMANS; IRON; LIVER; MALE; MIDDLE AGED; MUTATION; PEDIGREE; ZEBRAFISH;

EID: 50549095186     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.05.028     Document Type: Article

References (30)

1. Hentze M.W., Muckenthaler M.U., and Andrews N.C. Balancing acts: molecular control of mammalian iron metabolism. Cell 117 (2004) 285-297
2. De Domenico I., McVey Ward D., and Kaplan J. Regulation of iron acquisition and storage: consequences for iron-linked disorders. Nat Rev Mol Cell Biol 9 (2008) 72-81
3. Ganz T. Hepcidin and its role in regulating systemic iron metabolism. Hematol Am Soc Hematol Edu Prog 507 (2006) 29-35
4. Nemeth E., Tuttle M.S., Powelson J., Vaughn M.B., Donovan A., Ward D.M., et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306 (2004) 2090-2093
5. Pietrangelo A. The ferroportin disease. Blood Cells Mol Dis 32 (2004) 131-138
6. Devalia V., Carter K., Walker A.P., Perkins S.J., Worwood M., May A., et al. Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3). Blood 100 (2002) 695-697
7. Corradini E., Ferrara F., Pollicino T., Vegetti A., Abbati G.L., Losi L., et al. Disease progression and liver cancer in the ferroportin disease. Gut 56 (2007) 1030-1032
8. Gandon Y., Olivié D., Guyader D., Aubé C., Oberti F., Sebille V., et al. Non-invasive assessment of hepatic iron stores by MRI. Lancet 363 (2004) 357-362
9. Cremonesi L, Forni GL, Soriani N, Lamagna M, Fermo I, Daraio F, et al. Genetic and clinical heterogeneity of ferroportin disease. Br J Haematol 2005;131:663-670. Erratum in: Br J Haematol 2006;132:806.
10. Biasiotto G., Roetto A., Daraio F., Polotti A., Gerardi G.M., Girelli D., et al. Identification of new mutations on hepcidin and hemojuvelin in patients with HFE C282Y allele. Blood Cells Mol Dis 33 (2004) 338-343
11. De Domenico I., Ward D.M., Nemeth E., Vaughn M.B., Musci G., Ganz T., et al. The molecular basis of ferroportin-linked hemochromatosis. Proc Natl Acad Sci USA 102 (2005) 8955-8960
12. De Domenico I., Vaughn M.B., Li L., Bagley D., Musci G., Ward D.M., et al. Ferroportin-mediated mobilization of ferritin iron precedes ferritin degradation by the proteasome. EMBO J 25 (2006) 5396-5404
13. De Domenico I., Vaughn M.B., Yoon D., Kushner J.P., Ward D.M., and Kaplan J. Zebrafish as a model for defining the functional impact of mammalian ferroportin mutations. Blood 110 (2007) 3780-3783
14. Bozzini C., Campostrini N., Trombini P., Nemeth E., Castagna A., Tenuti I., et al. Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis. Blood Cells Mol Dis 40 (2008) 347-352
15. Drakesmith H., Schimanski L.M., Ormerod E., Merryweather-Clarke A.T., Viprakasit V., Edwards J.P., et al. Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. Blood 106 (2005) 1092-1097
16. Schimanski L.M., Drakesmith H., Merryweather-Clarke A.T., Viprakasit V., Edwards J.P., Sweetland E., et al. In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations. Blood 105 (2005) 4096-4102
17. Liu X.B., Yang F., and Haile D.J. Functional consequences of ferroportin 1 mutations. Blood Cells Mol Dis 35 (2005) 33-46
18. De Domenico I., Ward D.M., Musci G., and Kaplan J. Iron overload due to mutations in ferroportin. Haematologica 91 (2006) 92-95
19. Lieschke G.J., and Currie P.D. Animal models of human disease: zebrafish swim into view. Nat Rev Genet 8 (2007) 353-367
20. Carradice D., and Lieschke G.J. Zebrafish in hematology: sushi or science?. Blood 111 (2008) 3331-3342
21. Donovan A., Brownlie A., Zhou Y., Shepard J., Pratt S.J., Moynihan J., et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403 (2000) 776-781
22. Pietrangelo A. Hemochromatosis: an endocrine liver disease. Hepatology 46 (2007) 1291-1301
23. Beaton M., Guyader D., Deugnier Y., Moirand R., Chakrabarti S., and Adams P. Noninvasive prediction of cirrhosis in C282Y-linked hemochromatosis. Hepatology 36 (2002) 673-678
24. Morrison E.D., Brandhagen D.J., Phatak P.D., Barton J.C., Krawitt E.L., El-Serag H.B., et al. Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis. Ann Intern Med 138 (2003) 627-633
25. Gualdi R., Casalgrandi G., Montosi G., Ventura E., and Pietrangelo A. Excess iron into hepatocytes is required for activation of collagen type I gene during experimental siderosis. Gastroenterology 107 (1994) 1118-1124
26. Papanikolaou G., Tzilianos M., Christakis J.I., Bogdanos D., Tsimirika K., MacFarlane J., et al. Hepcidin in iron overload disorders. Blood 105 (2005) 4103-4105
27. Kemna E.H., Tjalsma H., Podust V.N., and Swinkels D.W. Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications. Clin Chem 53 (2007) 620-628
28. Origa R., Galanello R., Ganz T., Giagu N., Maccioni L., Faa G., et al. Liver iron concentrations and urinary hepcidin in beta-thalassemia. Haematologica 92 (2007) 583-588
29. Harrison-Findik D.D., Schafer D., Klein E., Timchenko N.A., Kulaksiz H., Clemens D., et al. Alcohol metabolism-mediated oxidative stress down-regulates hepcidin transcription and leads to increased duodenal iron transporter expression. J Biol Chem 281 (2006) 22974-22982
30. Nishina S., Hino K., Korenaga M., Vecchi C., Pietrangelo A., Mizukami Y., et al. Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription. Gastroenterology 134 (2008) 226-238